Literature DB >> 19177580

Burning hepatic fat: therapeutic potential for liver-specific thyromimetics in the treatment of nonalcoholic fatty liver disease.

Marco Arrese.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19177580     DOI： 10.1002/hep.22783

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  10 in total

Review 1.  Inflammation and fibrogenesis in steatohepatitis.

Authors:  Hideki Fujii; Norifumi Kawada
Journal:  J Gastroenterol       Date:  2012-02-07       Impact factor: 7.527

2.  Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels?

Authors:  Lucia Carulli; Stefano Ballestri; Amedeo Lonardo; Francesca Lami; Enrico Violi; Luisa Losi; Lisa Bonilauri; Anna Maria Verrone; Maria Rosaria Odoardi; Federica Scaglioni; Marco Bertolotti; Paola Loria
Journal:  Intern Emerg Med       Date:  2011-05-11       Impact factor: 3.397

3.  Pharmacological agents for nonalcoholic steatohepatitis.

Authors:  Maeva Guillaume; Vlad Ratziu
Journal:  Hepatol Int       Date:  2013-11-19       Impact factor: 6.047

Review 4.  Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation.

Authors:  Yan-Yun Liu; Gregory A Brent
Journal:  Trends Endocrinol Metab       Date:  2009-12-16       Impact factor: 12.015

5.  Leptin ameliorates insulin resistance and hepatic steatosis in Agpat2-/- lipodystrophic mice independent of hepatocyte leptin receptors.

Authors:  Víctor A Cortés; Kelly M Cautivo; Shunxing Rong; Abhimanyu Garg; Jay D Horton; Anil K Agarwal
Journal:  J Lipid Res       Date:  2013-11-30       Impact factor: 5.922

6.  Liver and diabetes. A vicious circle.

Authors:  Paola Loria; Amedeo Lonardo; Frank Anania
Journal:  Hepatol Res       Date:  2013-01       Impact factor: 4.288

Review 7.  Translational approaches: from fatty liver to non-alcoholic steatohepatitis.

Authors:  Natalia Rosso; Norberto C Chavez-Tapia; Claudio Tiribelli; Stefano Bellentani
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

8.  Hypoadiponectinemia and its association with liver fibrosis in morbidly obese patients.

Authors:  Leyla Nazal; Arnoldo Riquelme; Nancy Solís; Margarita Pizarro; Alex Escalona; Mauricio Burotto; Juan Ignacio Méndez; Catalina Saint-Jean; María José Concha; Stefano Giovanni; Diego Awruch; Arturo Morales; Rene Baudrand; Gonzalo Carrasco; María Angélica Domínguez; Oslando Padilla; Manuel Espinoza; Juan Francisco Miquel; Flavio Nervi; Marco Arrese
Journal:  Obes Surg       Date:  2010-01-12       Impact factor: 4.129

9.  Thyroid function and non-alcoholic fatty liver disease in hyperthyroidism patients.

Authors:  Bairong Wang; Baomin Wang; Yumei Yang; Jing Xu; Mengyang Hong; Mingfeng Xia; Xiaomu Li; Xin Gao
Journal:  BMC Endocr Disord       Date:  2021-02-18       Impact factor: 2.763

10.  Selective thyroid hormone receptor modulators.

Authors:  Girish Raparti; Suyog Jain; Karuna Ramteke; Mangala Murthy; Ravi Ghanghas; Sunita Ramanand; Jaiprakash Ramanand
Journal:  Indian J Endocrinol Metab       Date:  2013-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.